alrestatin has been researched along with nadp in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Das, B; Hair, GA; Srivastava, SK | 1 |
Bohren, KM; Ehrig, T; Gabbay, KH; Prendergast, FG | 1 |
Bohren, KM; Gabbay, KH; Harrison, DH; Petsko, GA; Ringe, D | 1 |
3 other study(ies) available for alrestatin and nadp
Article | Year |
---|---|
Activated and unactivated forms of human erythrocyte aldose reductase.
Topics: Aldehyde Reductase; Diabetes Mellitus; Enzyme Activation; Erythrocytes; Glucose; Glyceraldehyde; Humans; Imidazoles; Imidazolidines; Isoquinolines; Kinetics; NADP; Quercetin; Sorbitol; Sugar Alcohol Dehydrogenases | 1985 |
Mechanism of aldose reductase inhibition: binding of NADP+/NADPH and alrestatin-like inhibitors.
Topics: Aldehyde Reductase; Base Sequence; Binding Sites; Coenzymes; Isoquinolines; Molecular Sequence Data; Mutation; NADP; Oligodeoxyribonucleotides; Protein Binding; Recombinant Proteins; Spectrometry, Fluorescence; Tryptophan | 1994 |
The alrestatin double-decker: binding of two inhibitor molecules to human aldose reductase reveals a new specificity determinant.
Topics: Aldehyde Reductase; Binding Sites; Crystallization; Crystallography, X-Ray; Drug Design; Enzyme Inhibitors; Escherichia coli; Humans; Isoquinolines; Kinetics; Models, Molecular; Molecular Structure; NADP; Protein Binding; Protein Conformation; Protein Structure, Secondary; Protein Structure, Tertiary; Recombinant Proteins; Substrate Specificity | 1997 |